Apheresis. Biotechnology and the rheumatic diseases

Is malignancy a major concern in rheumatoid arthritis patients?

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008

Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.

Rheumatology (Oxford, England)·2007

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Arthritis and rheumatism·2002

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

Annals of internal medicine·2001

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

Arthritis research·2000

Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis.

The Journal of rheumatology·2000

Regional distribution of adult rheumatologists.

Arthritis and rheumatism·2013

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Arthritis and rheumatism·2013

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Arthritis and rheumatism·2013

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Arthritis and rheumatism·2013

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Arthritis and rheumatism·2013

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Arthritis and rheumatism·2013

Crocin as a multimodal therapy for multiple sclerosis: Recent breakthroughs in immunomodulation and neuroprotection.

Current journal of neurology·2026

SLC25A38 gene modification mediated by CRISPR/Cas9 in HEK293T cell line.

Journal of applied genetics·2026

Long-term efficacy and predictors of response to greater occipital nerve pulsed radiofrequency in migraine with prior preventive treatment failure.

Acta neurologica Belgica·2026

Adipose-Derived Stem Cells in Ophthalmic Regenerative Medicine: From Cell Replacement to Precision Engineering.

Stem cell reviews and reports·2026

Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs.

Tissue engineering and regenerative medicine·2026

Self-Amplifying RNA-Based Therapeutics: Advances, Challenges, and Future Perspectives.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Videos

Apheresis. Biotechnology and the rheumatic diseases

Related Concept Videos

Is malignancy a major concern in rheumatoid arthritis patients?

Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset.

Synovitis occurs in some clinically normal and asymptomatic joints in patients with early arthritis.

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Crocin as a multimodal therapy for multiple sclerosis: Recent breakthroughs in immunomodulation and neuroprotection.

SLC25A38 gene modification mediated by CRISPR/Cas9 in HEK293T cell line.

Long-term efficacy and predictors of response to greater occipital nerve pulsed radiofrequency in migraine with prior preventive treatment failure.

Adipose-Derived Stem Cells in Ophthalmic Regenerative Medicine: From Cell Replacement to Precision Engineering.

Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs.

Self-Amplifying RNA-Based Therapeutics: Advances, Challenges, and Future Perspectives.

Related Experiment Videos

Apheresis. Biotechnology and the rheumatic diseases

Related Concept Videos

Related Articles